Nesvategrast (OTT166)

nesvategrast · OcuTerra Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nesvategrast (OTT166), covering 2024-08-09 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Nesvategrast (OTT166) in Diabetic Retinopathy (DR) [Phase 2]